Hereditary hemorrhagic telangiectasia, liver disease and elevated serum testosterone (Osler–Weber–Rendu syndrome): a case report by unknown
Dissanayake et al. BMC Res Notes  (2017) 10:58 
DOI 10.1186/s13104-017-2397-z
CASE REPORT
Hereditary hemorrhagic telangiectasia, 
liver disease and elevated serum testosterone 
(Osler–Weber–Rendu syndrome): a case report
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Abstract 
Background: A Sri Lankan girl with hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome) is 
described.
Case presentation: She presented with recurrent spontaneous epistaxis, pulmonary arterio venous malformation 
and oral telangiectasia. A diagnosis of Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome) was 
made based on the presence of three Curacao criteria (out of four). Evaluations of her jaundice revealed chronic 
parenchymal liver disease with multiple nodules in the liver with early portal hypertension. She had a muscular build, 
with elevated serum testosterone but low serum dehydroepiandrosterone sulphate levels. This could be attributed to 
impaired sulfation of dehydroepiandrosterone due to portocaval shunting of blood, leading to hyperandrogenemia.
Conclusions: Hyperandorogenemia due impaired sulfation of dehydroepiandrosterone as a result of portocaval 
shunting is seen in Hereditary haemorrhagic telangiectasia.
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Case description
Background
A 16-year old girl from a remote village in Sri Lanka is 
described.
Case presentation
She was referred from the Paediatric Cardiology Unit to 
the University Unit of Lady Ridgeway Hospital for Chil-
dren (LRH) for further evaluation of jaundice. She was the 
only child born to non consanguineous healthy parents 
and was well till 14 years of age, when she sought medical 
advice from the local hospital for exertional dyspnoea. At 
presentation to the local hospital she was detected to have 
central cyanosis and clubbing but otherwise clinically 
normal. Her haemoglobin was 18 g/dl and the packed cell 
volume was 54%. Her platelet count was 73 ×  109/l and 
SpO2 82%. The echocardiogramme revealed a pulmo-
nary arteriovenous malformation (AVM). The ultra sound 
scan (USS) of the abdomen showed a normal liver and no 
splenomegaly.
She was referred to the cardiology unit of LRH for fur-
ther evaluation. At LRH contrast echocardiogramme was 
performed which showed evidence of pulmonary arte-
riovenous fistula. The finding at cardiac catheterization 
was compatible with bilateral diffuse pulmonary AVMs. 
Due to the diffuse nature of the pulmonary AVM she was 
managed conservatively.
Two years later, at the age of 16  years she developed 
spontaneous recurrent epistaxis. She was also noted 
to have jaundice. Examination revealed deep jaundice, 
plethora, central cyanosis and clubbing. There were no 
other peripheral stigmata of chronic liver disease. She 
had coarse facial appearance. There was no cutaneous 
telangiectasia. Abdominal examination revealed a firm 
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hepatomegaly of two cm, but no splenomegaly or ascites. 
Rest of the abdominal examination was normal. Cardio-
vascular system examination revealed a systolic murmur 
best heard over the pulmonary area. Blood pressure was 
normal. Rest of the examination including respiratory 
system and central nervous systems were clinically nor-
mal. Ultra sound scan examination of abdomen at six-
teen years revealed heterogeneous linear (Liver) echo 
texture, increased peri portal echogenicity with spleno-
megaly and varices compatible with chronic liver disease 
and early portal hypertension. A focal lesion was seen 
in segment Vl of the liver. Magnetic resonance imaging 
(MRI) revealed a dilated splenic vein draining separately 
through the diaphragmatic hiatus between the inferior 
vena cava and the aorta possibly into the superior vena 
cava through the azygous vein. She continued to be man-
aged conservatively.
At nineteen years of age she remained jaundiced. There 
were telangiectases over the oral mucosa and conjunc-
tiva. Eye referral revealed telangiectatic vessels in the 
right optic disc. Hepatomegaly was unchanged.
She had attained menarche at 16  year of age but had 
amenorrhea for several years, and now has her menstrual 
periods infrequently. Although she has a masculine habi-
tus her secondary sexual characteristics were feminine. 
There was no clitoromegaly. Endocrinological evalua-
tion was done to investigate for her masculine built and 
irregular menstruation. There was no family history 
suggestive of polycystic ovarian syndrome. At 19  years 
of age, she had an elevated serum testosterone level of 
15.97 nmol/L (normal adult female range 0.52–2.43), but 
serum DHEAS (dehydroepiandrosterone sulfate) level 
were low (1.0 μmol/L, normal range 1.7–13.4). Serum 17 
OHP, FSH, LH and serum estradiol levels were normal. 
She also had marginally low free T4, with normal TSH. 
USS abdomen repeated at 19 years of age was compatible 
with chronic liver disease with early portal hypertension. 
She had normal uterus and normal ovaries with no evi-
dence of poly cystic ovaries.
MRI abdomen (Fig.  1) showed changes of chronic 
parenchymal liver disease with multiple nodules in both 
lobes of the liver. The nodules were hyperplastic with low 
T2 signal intensity. A 47 × 45 mm size nodule was seen 
in the right lobe of the liver. A liver biopsy was not done 
due to the risk of bleeding in the presence of multiple 
AVMs. MRI brain done to identify any cerebral vascular 
malformation was normal.
A diagnosis of hereditary hemorrhagic telangiectasia 
(Osler–Weber–Rendu syndrome) was made based on 
the presence of three out of four Curacao criteria [1]. The 
three criteria she fulfilled were recurrent spontaneous 
epistaxis, visceral (pulmonary) arterio venous malforma-
tion and telangiectasia in the oral mucosa [1]. The patient 
along with the family was counselled regarding the diag-
nosis and the prognosis.
Conclusion
This 19 year old girl has Hereditary haemorrhagic telan-
giectasia with chronic liver disease and pulmonary AVM. 
She has a masculine appearance due to impaired sulfa-
tion of dehydroepiandrosterone (DHEA) as a result of 
portocaval shunting.
Hereditary hemorrhagic telangiectasia—HHT (Osler–
Weber–Rendu syndrome) was first described in the 
nineteenth century as a familial disorder causing nose 
bleeds, gastrointestinal bleeding and abnormal vascu-
lar structures. It is inherited as an autosomal dominant 
trait. A diagnosis of HHT could be made based on Cura-
cao’s criteria, which are; Spontaneous recurrent epistaxis, 
multiple telangiectases at characteristic sites such as lips, 
oral cavity, fingers, nose, visceral lesions such as gastro-
intestinal telangiectasia, pulmonary AVM, hepatic AVM, 
Cerebral AVM and spinal AVM, a family history of a first 
degree relative with HHT. The presence of three criteria 
makes it a definite diagnosis of HHT, while two make the 
diagnosis possible. Our patient had spontaneous recur-
rent epistaxis, visceral AVM in the form of pulmonary 
AVM and telangiectasia in the oral mucosa. There was 
no family history of HHT. Based on these three criteria a 
definitive diagnosis of HHT was made [1]. The diagnosis 
was made at 19 years of age as the telangiectasia of the 
oral mucosa appeared only at nineteen years.
Spontaneous recurrent nose bleeds from telangiectasia 
of the nasal mucosa are the most common manifestations 
of HHT and occurs in about 95% [2]. Intervention for 
epistaxis should be considered if there is anaemia attrib-
utable to nose bleeding or if the frequency and duration 
of bleeding interferes with normal activities [2]. Our 
Fig. 1 Magnetic resonance imaging showing multiple nodules in 
the liver
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patient required no treatment as the epistaxis was self-
limiting. Telangiectases of the skin and buccal mucosa 
also occur in about 95% of patients, typically presenting 
later in life than epistaxis [2]. It usually presents in about 
the third decade of life and gradually increases in num-
ber and size. They mostly occur in the face, lips, tongue, 
buccal mucosa and finger tips and can occur elsewhere. 
Our patient had telangiectases over the oral mucosa and 
conjunctivae.
Pulmonary AVMs are thin walled abnormal vessels 
that replace normal capillaries between pulmonary arte-
rial and venous circulation. In one study 37% of patients 
with HHT demonstrated pulmonary AVM on high reso-
lution computed tomography (CT). The safest method 
for treatment is transcatheter embolisation. Since our 
patient had bilateral diffuse pulmonary AVM conserva-
tive management was planned. Cerebral AVMs occur in 
approximately 10% of patients with HHT [2]. They can 
cause headache, seizures, ischaemia of the surrounding 
tissue, or haemorrhage. Our patient did not have cerebral 
involvement.
Hepatic involvement is variable in HHT. In one study 
only 8% showed symptomatic involvement [2]. In HHT, 
the predominant liver involvement seen was shunting of 
blood from hepatic artery to hepatic veins with shunting 
of metabolites from portal circulation to systemic circu-
lation. A shunt from hepatic artery to portal vein leads 
to portal hypertension and increased blood flow can lead 
to nodularity of the liver due to increased deposition of 
fibrous tissue. The liver undergoes nodular transforma-
tion also known as “pseudo-cirrhosis” [3]. In our patient 
there was no vascular malformation of the liver however 
nodular hyperplasia was seen. She did not undergo liver 
biopsy as there is a risk of bleeding. Liver transplanta-
tion is currently the only curative option for symptomatic 
liver disease in HHT. Except for hepatocellular and bil-
iary necrosis which requires urgent liver transplantation 
consensus on the most appropriate timing of the trans-
plantation is lacking [4].
To our knowledge, elevated serum testosterone lev-
els have not previously been reported in females with 
HHT. However, there have been a few reported cases of 
elevated serum testosterone in association with porto-
systemic shunting in young females [5, 6]. The initial 
observation was reported in two adolescent girls with 
congenital porto-systemic shunting, who presented with 
virilisation and amenorrhea, and had elevated testos-
terone [5]. More recently, Bas et al. [6] reported on two 
7-year old girls with congenital portosystemic shunts, 
presenting with premature pubarche. These females 
had elevated serum testosterone and other downstream 
androgens in the presence of low DHEAS, as seen in our 
patient [6]. It is postulated that the mechanism of hyper-
androgenemia, could be impaired conversion of DHEA 
to its inactive sulphate ester DHEAS in the liver, due to 
bypassing of DHEA to the systemic circulation [6]. This 
would lead to low DHEAS and elevated DHEA in the 
circulation. As DHEA is a precursor for the synthesis of 
more potent downstream androgens such as androsten-
edione and testosterone, elevated DHEA would lead to 
elevated serum testosterone and features of hyperandro-
genism [6].
This is a classical case of HHT with hyperandrogenae-
mic features. This probably could be the first reported 
case with hyperandrogenaemia secondary to hepatic 
AVM leading to shunting of blood leading to underclear-
ance of proandrogenic metabolites from the circulation.
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